Pharmas continue this R&D this year too
New drug development will continue.
Major Korean pharmaceutical companies have a plan to export new drug pipelines and commercialize them. In order to export, transfer and commercialize technology, they have more actively invested funds into R&D.
In particular, some of these pipelines have attr...
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.